12/2/2022

Tramadol Tablets

Products Affected - Description

- Tramadol tablet, Major, 50 mg, bottle, 100 count, NDC 00904-6365-61 - discontinued
- Tramadol tablet, Marlex, 50 mg, bottle, 100 count, NDC 10135-0519-01
- Tramadol tablet, Marlex, 50 mg, bottle, 500 count, NDC 10135-0519-05
- Tramadol tablet, Marlex, 50 mg, bottle, 1000 count, NDC 10135-0519-10
- Tramadol tablet, Mylan (Viatris), 50 mg, bottle, 100 count, NDC 00378-4151-01 - discontinued
- Tramadol tablet, Mylan (Viatris), 50 mg, bottle, 500 count, NDC 00378-4151-05 - discontinued
- Tramadol tablet, Mylan (Viatris), 50 mg, unit-dose blister pack, 100 count, NDC 51079-0991-20 - discontinued
- Tramadol tablet, Teva, 50 mg, bottle, 100 count, NDC 00093-0058-01
- Tramadol tablet, Virtus, 50 mg, bottle, 100 count, NDC 69543-0136-10 - discontinued
- Tramadol tablet, Virtus, 50 mg, bottle, 500 count, NDC 69543-0136-50 - discontinued
- Tramadol tablet, Virtus, 50 mg, bottle, 1000 count, NDC 69543-0136-11 - discontinued

Reason for the Shortage

- Amneal has tramadol tablets available.
- Major discontinued tramadol tablets.
- Marlex did not provide a reason for the shortage.
- Mylan discontinued tramadol tablets in late-2021.
- Sun Pharma has tramadol tablets available.
- Teva did not provide a reason for the shortage.
- Virtus discontinued tramadol tablets.

Available Products

- Tramadol tablet, Amneal, 50 mg, bottle, 100 count, NDC 65162-0627-10
- Tramadol tablet, Amneal, 50 mg, bottle, 500 count, NDC 65162-0627-50
- Tramadol tablet, Amneal, 50 mg, bottle, 1000 count, NDC 65162-0627-11
- Tramadol tablet, Sun Pharma, 50 mg, bottle, 100 count, NDC 57664-0377-08
- Tramadol tablet, Sun Pharma, 50 mg, bottle, 500 count, NDC 57664-0377-13
- Tramadol tablet, Sun Pharma, 50 mg, bottle, 1000 count, NDC 57664-0377-18
- Tramadol tablet, Teva, 50 mg, bottle, 500 count, NDC 00093-0058-05

Estimated Resupply Dates

- Marlex has tramadol 50 mg tablets on back order and the company cannot estimate a release date.
- Teva has tramadol 50 mg tablets in 100 count on back order and the company estimates a release date of late-January 2023.

Updated

Updated December 2, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 21, 2020 by Rachael Freeman, PharmD, BCPS. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.